MEDICUS PHARMA LTD. Increase (Decrease) in Accounts Payable
MEDICUS PHARMA LTD. (MDCX) reported Increase (Decrease) in Accounts Payable of $404.67 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2025-08-11
- MEDICUS PHARMA LTD. increase (decrease) in accounts payable for the quarter ending 2025-06-30 was -$250.96K, a 186.25% decline year-over-year.
- MEDICUS PHARMA LTD. increase (decrease) in accounts payable for the quarter ending 2025-03-31 was $655.63K, a 79.98% increase year-over-year.
- MEDICUS PHARMA LTD. increase (decrease) in accounts payable for the quarter ending 2024-06-30 was $290.97K.
- MEDICUS PHARMA LTD. increase (decrease) in accounts payable for the quarter ending 2024-03-31 was $364.27K.
- MEDICUS PHARMA LTD. increase (decrease) in accounts payable for fiscal 2024 was $808.75K, a 922.59% increase from fiscal 2023.
- MEDICUS PHARMA LTD. increase (decrease) in accounts payable for fiscal 2023 was $79.09K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|
| 2025-06-30 | -$250.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $404.67K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $655.63K 10-Q · filed 2025-05-12 | ||
| 2024-12-31 | $808.75K 10-K · filed 2025-03-28 | ||
| 2024-06-30 | $290.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $655.24K 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $364.27K 10-Q · filed 2025-05-12 | ||
| 2023-12-31 | $79.09K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |